BioPivot review
By Aminoscope editorial desk · Aminoscope
Plan prices, billing terms to confirm
Our verdict
BioPivot lists monthly and quarterly figures for each of its two compounded injection programs. The semaglutide starter card shows $185 monthly or $400 quarterly, and the tirzepatide starter card shows $242 or $590. The semaglutide billing comparison separates listed prices from what is actually charged. Ask for the first payment, renewal schedule and treatment supply before you enroll.
Main trade-offs
- Public documents describe different billing intervals
- The cancellation policy retains $59 after a clinical denial
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Readers comparing published plan prices and willing to confirm their billing terms before paying.
Consider other options if
Readers who need a confirmed first debit, renewal date, or pharmacy assignment before intake.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Starter listings: compounded semaglutide $185 monthly or $400 quarterly, tirzepatide $242 monthly or $590 quarterly. Confirm the selected billing schedule.
- Medications
- Compounded semaglutide injection · Compounded tirzepatide injection
- Insurance
- Cash-pay, no insurance
- Availability
- Confirm state and treatment availability
Our review in detail
Full assessment
Starter listings: compounded semaglutide $185 monthly or $400 quarterly, tirzepatide $242 monthly or $590 quarterly. Confirm the selected billing schedule.
What it is
BioPivot describes itself as a telehealth platform. Its homepage names Elite Care Health for clinical care and Rx Ave Health for pharmacy and prescription fulfillment.
How care works
The provider reviews the intake and decides whether to prescribe. Confirm availability for your state and which pharmacy would fill your prescription.
Costs, billing and cancellation
BioPivot’s terms describe a bundled subscription. They give a 30-day charge interval in one clause and a product-specific interval in another. The cancellation policy describes a three-month membership. The public product cards list both intervals, so the selected agreement should establish which cadence and commitment apply.
Compounded semaglutide: starter $185 monthly or $400 quarterly, continuation $218 monthly or $490 quarterly, maintenance $225 monthly or $518 quarterly, microdosing $168 monthly or $370 quarterly. Quarterly billing is easy to miss, and the Peter MD review shows tirzepatide at $149 for the first month, then $249 a month billed quarterly.
Compounded tirzepatide: starter $242 monthly or $590 quarterly, continuation $315 monthly or $780 quarterly, maintenance $350 monthly or $900 quarterly, microdosing $220 monthly or $528 quarterly.
The cancellation policy says the $59 consultation charge is retained if a clinician reviews the intake and declines treatment. It describes a full refund before clinical review and says cancellation cannot be guaranteed once the order reaches the pharmacy.
Medication and evidence
The public treatment pages list compounded semaglutide and tirzepatide injections. Compounded medications are not FDA-approved. Ask which formulation and pharmacy apply to your prescription.
Pros and watch-outs
What we like
- Publishes monthly and quarterly figures by plan
- Names clinical care and pharmacy partners
Watch-outs
- Public documents describe different billing intervals
- The cancellation policy retains $59 after a clinical denial
Best for
Readers comparing published plan prices and willing to confirm their billing terms before paying.
Who should look elsewhere
Readers who need a confirmed first debit, renewal date, or pharmacy assignment before intake.
Research relevant to BioPivot
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- SURMOUNT-1 explained: the trial that made tirzepatide the benchmark
The landmark phase 3 trial of tirzepatide for obesity — the design, the up-to-20.9% weight loss, the safety profile, and the limits of what it proved.
How BioPivot compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our yourEra review, Bodybuilding Health+ review and Gala Health review describe what each service publishes about pricing, billing and cancellation.
yourEraComparing monthly billing and longer terms for compounded GLP-1 care
See yourEra →Bodybuilding Health+
GLP-1 and longevity options with named clinical and pharmacy partners
See Bodybuilding Health+ →
Gala HealthA guided, program-style GLP-1 weight-care experience
See Gala Health →
More GLP-1 telehealth reviews: Strut HealthGo Vida PlenaVyvronCenter for Medical Weight Loss (CMWL)Pinnacle AtlasAHBARx
Editorial research
How we assessed this. This review is based on BioPivot’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does BioPivot list for starter plans?
- Starter listings: compounded semaglutide $185 monthly or $400 quarterly, tirzepatide $242 monthly or $590 quarterly. Confirm the selected billing schedule.
- What happens if BioPivot’s clinician does not approve treatment?
- The public cancellation policy describes refunding the membership payment less a $59 consultation fee after clinical review.
- Is BioPivot legit?
- BioPivot is a GLP-1 telehealth service. The medications it names are Compounded semaglutide injection and Compounded tirzepatide injection. Its stated availability: Confirm state and treatment availability. What it publishes up front: Starter listings: compounded semaglutide $185 monthly or $400 quarterly, tirzepatide $242 monthly or $590 quarterly. Confirm the selected billing schedule. It is cash-pay and states it does not bill insurance. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees and how its intake works.